Evidence map›Paper›PMID 40312658›Full record

ArticleBMC public health2025

Global, regional, and national time trends in mortality for breast cancer, 1992-2021: an age-period-cohort analysis for the global burden of disease 2021 study.

Mengxia Fu, Zhiming Peng, Min Wu, Dapeng Lv, Shuzhen Lyu, Xia Zhao, Yanping Li, Huamin Qin

Abstract read
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mengxia Fu *Galactophore Department, Galactophore Center, Beijing Shijitan Hospital, Capital Medical University, Tieyi Road 10, Haidian District, Beijing, 100038, China. fmx3973@bjsjth.cn.
Zhiming Peng *Department of Orthopedics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Min WuGalactophore Department, Galactophore Center, Beijing Shijitan Hospital, Capital Medical University, Tieyi Road 10, Haidian District, Beijing, 100038, China.
Dapeng LvGalactophore Department, Galactophore Center, Beijing Shijitan Hospital, Capital Medical University, Tieyi Road 10, Haidian District, Beijing, 100038, China.
Shuzhen LyuGalactophore Department, Galactophore Center, Beijing Shijitan Hospital, Capital Medical University, Tieyi Road 10, Haidian District, Beijing, 100038, China.
Xia ZhaoGalactophore Department, Galactophore Center, Beijing Shijitan Hospital, Capital Medical University, Tieyi Road 10, Haidian District, Beijing, 100038, China.
Yanping LiGalactophore Department, Galactophore Center, Beijing Shijitan Hospital, Capital Medical University, Tieyi Road 10, Haidian District, Beijing, 100038, China.
Huamin QinDepartment of Pathology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China. qinhuamin6@hotmail.com.

Funding

Incubating Program of Beijing Municipal Administration of Hospitals PX2024027
6 · The paper itself

Abstract

backgroundBreast cancer remains a major global health concern. This study aims to assess the epidemiological trends of breast cancer, with a focus on mortality rates, primary risk factors, and their associations with age, time period, and birth cohort.

methodsMortality data were obtained from the Global Burden of Disease Study 2021. An age-period-cohort model was employed to analyze trends in breast cancer mortality and its primary risk factors.

resultsGlobally, breast cancer outcomes remained poor between 1992 and 2021, with an estimated 660925.3 deaths in 2021. Mortality rates declined significantly in high and high-middle socio-demographic index (SDI) countries [-1.56%, 95% CI (-1.7 to -1.43)], [-1.03% (-1.11 to -0.94), respectively], but increases markedly in low-middle SDI countries [1.18% (1.13 to 1.23)], with little change in other regions. A global shift in breast cancer-related deaths from younger to older age groups was observed, and mortality increased sharply with advancing age. Positive period and cohort effects were primarily seen in high and high-middle SDI countries, whereas adverse effects were more common in lower-SDI regions. Diets high in red meat emerged as the leading risk factor for breast cancer mortality worldwide, although favorable trends were noted in high and high-middle SDI countries.

conclusionsDespite a global decline in breast cancer mortality, many countries continue to experience unfavorable period and cohort effects. A notable rise in mortality among individuals aged 80 and older was observed across all SDI quintiles, underscoring the urgent need to strengthen healthcare systems for aging breast cancer populations worldwide.

Indexed as

Breast NeoplasmsGlobal Burden of DiseaseGlobal HealthAdultAgedAged, 80 and overAge FactorsCohort StudiesFemaleHumansMiddle AgedMortalityRisk FactorsYoung AdultAge-period-cohortBreast cancerMortalityRisk factor

Identifiers

PMID40312658
PMCPMC12044940

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.